Jaguar Animal Health (JAGX)
(Delayed Data from NSDQ)
$4.22 USD
-0.07 (-1.63%)
Updated May 31, 2024 04:00 PM ET
After-Market: $4.30 +0.08 (1.90%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Brokerage Reports
Jaguar Animal Health, Inc. [JAGX]
Reports for Purchase
Showing records 21 - 29 ( 29 total )
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar enters binding agreement to merge with Napo Pharmaceuticals
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar inks Canalevia deal with Eli Lilly?s Elanco animal health subsidiary
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Q3 loss better than expected, awaiting additional year-end developments
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Q2 cash burn better than anticipated, business development discussions continue
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Q1 cash burn better than expected, focus on equine correct, in our view
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar Q4 cash burn inline with expectations, additional cash needed, lower to BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar goes after dogs, cats, horses and calves - initiate with STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B